Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Denmark- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Denmark39 clinical trials in Gandrup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on knee osteoarthritis treatments, including innovative pain management solutions and cartilage regeneration therapies. Multiple trials are evaluating new medications and therapeutic approaches.
Studies include novel treatments like diclofenac gel and experimental compounds for pain relief and joint health.
Innovative trials addressing obesity and type 2 diabetes, with a focus on weight management therapies combined with lifestyle modifications.
Research includes dual-approach treatments targeting both weight loss and diabetic control in patients with combined conditions.
Groundbreaking studies in atherosclerotic cardiovascular disease prevention and treatment, focusing on reducing major adverse cardiovascular events.
Clinical trials are evaluating new medications for preventing cardiac events in high-risk populations.
Important research into Alzheimer's disease and migraine treatments, including pediatric studies for headache prevention.
Trials include innovative treatments for early-stage Alzheimer's and specialized migraine therapies for young patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.